Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

What is recommended for maintenance therapy of recurrent major depressive disorder?

Maintaining remission in recurrent major depressive disorder relies on ongoing pharmacologic stabilization together with psychosocial support. Continuing the same antidepressant at an effective dose provides sustained neurotransmitter modulation that helps prevent relapse, and stopping or changing therapy too soon or without adding support increases the risk of recurrence. Adding psychotherapy augments medication by addressing cognitive patterns, coping strategies, and life stressors, which is especially beneficial when there have been multiple episodes. This combined approach typically offers better protection against relapse than either approach alone, and it avoids the disruption and potential withdrawal or destabilization that can come with stopping therapy or altering the regimen.

Maintaining remission in recurrent major depressive disorder relies on ongoing pharmacologic stabilization together with psychosocial support. Continuing the same antidepressant at an effective dose provides sustained neurotransmitter modulation that helps prevent relapse, and stopping or changing therapy too soon or without adding support increases the risk of recurrence. Adding psychotherapy augments medication by addressing cognitive patterns, coping strategies, and life stressors, which is especially beneficial when there have been multiple episodes. This combined approach typically offers better protection against relapse than either approach alone, and it avoids the disruption and potential withdrawal or destabilization that can come with stopping therapy or altering the regimen.